No products
View larger AOB8067
CAS: 693241-54-2
Chemical Name: 2-[[4-[(2-Methoxybenzoyl)amino]benzoyl]amino]-benzoic acid
100 Items
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $31.45 | Total: $157.25 |
| 1 | 10 | $26.64 | Total: $266.40 |
| 1 | 25 | $22.57 | Total: $564.25 |
| 1 | 50 | $19.24 | Total: $962.00 |
| 1 | 100 | $16.65 | Total: $1,665.00 |
| Molecular Formula | C22H18N2O5 |
| Molecular Weight | 390.40 |
| CAS Numbers | 693241-54-2 |
| Storage Condition | 0°C (short term), -20°C (long term), desiccated |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| Synonym | EG-1; EG 1 |
| IUPAC/Chemical Name | 2-[[4-[(2-Methoxybenzoyl)amino]benzoyl]amino]-benzoic acid |
| InChl Key | GYZZRJRJYVMXNS-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C22H18N2O5/c1-29-19-9-5-3-7-17(19)21(26)23-15-12-10-14(11-13-15)20(25)24-18-8-4-2-6-16(18)22(27)28/h2-13H,1H3,(H,23,26)(H,24,25)(H,27,28) |
| SMILES Code | O=C(O)C1=CC=CC=C1NC(C2=CC=C(NC(C3=CC=CC=C3OC)=O)C=C2)=O |
| References | 1) Smith CB, et al., Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723. doi: 10.14694/EDBK_175474. PubMed PMID: 28561696. 2) Masuda K, et al.' Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. J Gastroenterol. 2017 May 29. doi: 10.1007/s00535-017-1352-z. [Epub ahead of print] PubMed PMID: 28555325. |
Novel specific inhibitor of Pax2 transcription activation, targeting the DNA binding domain and inhibiting embryonic kidney development